Novavax | NVAX - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Adma Biologics USD 45.33M 4.05M 2026-03
Agenus USD 39.17M 49.8M 2026-03
AstraZeneca USD 2.51B 573M 2026-06
BioCryst Pharmaceuticals USD 78.4M 167.45M 2026-06
Cassava Sciences USD -10.33M 2.21M 2026-03
Geron USD -3.64M 27.5M 2026-03
GlaxoSmithKline GBP 435M 1.3B 2026-06
MannKind USD -16.62M 671K 2026-03
Merck USD -1.34B 2.9B 2026-06
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Moderna USD -1.34B 517M 2026-03
Novartis USD 3.16B 747M 2026-03
Novavax USD 17.53M 219.91M 2025-12
Pfizer USD -248M 2.94B 2026-06
Sanofi EUR 343M 1.27B 2026-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
TG Therapeutics USD 7.78M 12M 2026-06